Takeda Pharmaceutical Co LtdNYSE:TAK
- LAST PRICE13.2650
- TODAY'S CHANGE (%)0.0850 (0.6449%)
- Bid / Lots13.2600/ 62
- Ask / Lots13.2700/ 78
- Open / Previous Close13.2200 / 13.1800
- Day Range
- 52 Week Range
- Volume948,945
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | TAK |
|---|---|---|
| 09:32 ET | 37515 | 13.235 |
| 09:34 ET | 10017 | 13.245 |
| 09:36 ET | 10365 | 13.235 |
| 09:38 ET | 4289 | 13.225 |
| 09:39 ET | 30120 | 13.26 |
| 09:41 ET | 2560 | 13.26 |
| 09:43 ET | 10847 | 13.265 |
| 09:45 ET | 3900 | 13.28 |
| 09:48 ET | 6001 | 13.275 |
| 09:50 ET | 3335 | 13.275 |
| 09:52 ET | 4541 | 13.27 |
| 09:54 ET | 3949 | 13.265 |
| 09:56 ET | 1250 | 13.265 |
| 09:57 ET | 1251 | 13.275 |
| 09:59 ET | 9116 | 13.28 |
| 10:01 ET | 10162 | 13.265 |
| 10:03 ET | 2052 | 13.27 |
| 10:06 ET | 1106 | 13.265 |
| 10:08 ET | 4568 | 13.255 |
| 10:10 ET | 8430 | 13.265 |
| 10:12 ET | 3375 | 13.265 |
| 10:14 ET | 1514 | 13.265 |
| 10:15 ET | 3476 | 13.275 |
| 10:17 ET | 1213 | 13.275 |
| 10:19 ET | 200 | 13.275 |
| 10:21 ET | 6713 | 13.285 |
| 10:24 ET | 1300 | 13.285 |
| 10:26 ET | 5016 | 13.275 |
| 10:28 ET | 800 | 13.28 |
| 10:30 ET | 1300 | 13.275 |
| 10:32 ET | 7898 | 13.27 |
| 10:33 ET | 1132 | 13.265 |
| 10:35 ET | 1809 | 13.2601 |
| 10:37 ET | 8487 | 13.26 |
| 10:39 ET | 6275 | 13.2617 |
| 10:42 ET | 4968 | 13.265 |
| 10:44 ET | 12432 | 13.275 |
| 10:46 ET | 3953 | 13.275 |
| 10:48 ET | 14181 | 13.27 |
| 10:50 ET | 1870 | 13.265 |
| 10:51 ET | 3792 | 13.265 |
| 10:53 ET | 18498 | 13.265 |
| 10:55 ET | 31780 | 13.265 |
| 10:57 ET | 2234 | 13.265 |
| 11:00 ET | 838 | 13.26 |
| 11:02 ET | 4375 | 13.255 |
| 11:04 ET | 9244 | 13.27 |
| 11:06 ET | 544 | 13.27 |
| 11:08 ET | 1012 | 13.265 |
| 11:09 ET | 500 | 13.265 |
| 11:11 ET | 16700 | 13.27 |
| 11:13 ET | 25514 | 13.265 |
| 11:15 ET | 21477 | 13.265 |
| 11:18 ET | 19050 | 13.265 |
| 11:20 ET | 19627 | 13.265 |
| 11:22 ET | 18626 | 13.255 |
| 11:24 ET | 23073 | 13.255 |
| 11:26 ET | 22884 | 13.255 |
| 11:27 ET | 30627 | 13.28 |
| 11:29 ET | 2937 | 13.28 |
| 11:31 ET | 2384 | 13.28 |
| 11:33 ET | 10179 | 13.295 |
| 11:36 ET | 6074 | 13.3 |
| 11:38 ET | 26322 | 13.275 |
| 11:40 ET | 4392 | 13.27 |
| 11:42 ET | 2271 | 13.265 |
| 11:44 ET | 368 | 13.27 |
| 11:45 ET | 11683 | 13.26 |
| 11:47 ET | 6106 | 13.265 |
| 11:49 ET | 16880 | 13.265 |
| 11:51 ET | 2610 | 13.265 |
| 11:54 ET | 560 | 13.26 |
| 11:56 ET | 6473 | 13.265 |
| 11:58 ET | 17431 | 13.255 |
| 12:00 ET | 486 | 13.25 |
| 12:02 ET | 2470 | 13.245 |
| 12:03 ET | 2522 | 13.235 |
| 12:05 ET | 2227 | 13.235 |
| 12:07 ET | 3703 | 13.235 |
| 12:09 ET | 8039 | 13.25 |
| 12:12 ET | 2598 | 13.245 |
| 12:14 ET | 12193 | 13.255 |
| 12:16 ET | 24559 | 13.26 |
| 12:18 ET | 1534 | 13.255 |
| 12:20 ET | 1347 | 13.26 |
| 12:21 ET | 400 | 13.26 |
| 12:23 ET | 15139 | 13.265 |
| 12:25 ET | 2200 | 13.265 |
| 12:27 ET | 21912 | 13.265 |
| 12:30 ET | 52461 | 13.245 |
| 12:32 ET | 2276 | 13.245 |
| 12:34 ET | 800 | 13.245 |
| 12:36 ET | 2634 | 13.245 |
| 12:38 ET | 5040 | 13.245 |
| 12:39 ET | 23925 | 13.26 |
| 12:41 ET | 8856 | 13.255 |
| 12:43 ET | 2923 | 13.26 |
| 12:45 ET | 6790 | 13.26 |
| 12:48 ET | 925 | 13.255 |
| 12:50 ET | 7978 | 13.27 |
| 12:52 ET | 700 | 13.265 |
| 12:54 ET | 283 | 13.263 |
| 12:56 ET | 16897 | 13.2645 |
| 12:57 ET | 4292 | 13.265 |
| 12:59 ET | 735 | 13.265 |
Apr 8, 2024
Apr 1, 2024
*DJ Takeda Pharmaceutical: To Sell Nihon Pharmaceutical to Alinamin Pharmaceutical, from 2:08AM ET on Monday Apr 01, 2024 by Dow Jones
2:08AM ET on Monday Apr 01, 2024 by Dow Jones
Mar 27, 2024
Empathy in Action: Takeda's Global Initiative Brings IBD Challenges to the Forefront in the UAE, from 8:53AM ET on Wednesday Mar 27, 2024 by Dow Jones
8:53AM ET on Wednesday Mar 27, 2024 by Dow Jones
Mar 26, 2024
*DJ Takeda: Announces Candidates for Bd of Directors at Upcoming Hldrs Meeting, from 7:10PM ET on Tuesday Mar 26, 2024 by Dow Jones
7:10PM ET on Tuesday Mar 26, 2024 by Dow JonesTakeda Announces Candidates for Board of Directors at Upcoming Shareholders Meeting, from 7:07PM ET on Tuesday Mar 26, 2024 by Dow Jones
7:07PM ET on Tuesday Mar 26, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Takeda Pharmaceutical Co Ltd | 42.3B | 36.3x | -3.20% |
Xeris Biopharma Holdings Inc | 259.8M | -4.1x | --- |
Assertio Holdings Inc | 77.4M | -0.2x | --- |
Natural Alternatives International Inc | 41.2M | -9.6x | -18.19% |
Harrow Inc | 436.7M | -16.5x | --- |
Esperion Therapeutics Inc | 366.5M | -0.9x | --- |
Company Information
Takeda Pharmaceutical Company Limited is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the research, development, manufacture and sale of pharmaceutical products, General medical products, quasi drugs and healthcare products in Japan and overseas. The Company's research and development functions are concentrated in four areas of oncology (cancer), digestive system diseases, rare diseases and neurology (neuropsychiatric diseases), as well as two business units of plasma fractionation products and vaccines. The Company is engaged in the improvement of pipelines at research and development centers located mainly in Japan and the United States.
Contact Information
- Headquarters
- 4F, 2-1-1, Nihombashihon-choCHUO-KU, TKY, Japan 103-8668
- Phone
- ---
- Fax
- ---
Executives
- Chairman of Board of Directors, Independent Director
- Masami Iijima
- President, Chief Executive Officer, Representative Director
- Christophe Weber
- Chief Financial Officer, Director
- Costa Saroukos
- President of Research & Development, Vice President of Subsidiary, Director
- Andrew Plump
- Independent Director
- Olivier Bohuon
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $42.3B |
|---|---|
Revenue (TTM) | $27.0B |
Shares Outstanding | 3.2B |
Dividend Yield | 7.23% |
Annual Dividend Rate | 0.9586 USD |
Ex-Dividend Date | 09-27-23 |
Pay Date | 12-11-23 |
Beta | 0.60 |
EPS | $0.37 |
Book Value | $13.25 |
P/E Ratio | 36.3x |
Price/Sales (TTM) | 1.6 |
Price/Cash Flow (TTM) | 7.4x |
Operating Margin | 7.50% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
